DDJ Article · April 2026
CBCT in Dentistry: When is there diagnostic added value, and when is it overuse?
Cone Beam Computed Tomography is technically superior—but the question of when this advantage has therapeutic consequences is more clinically decisive than mere image quality.
Orientation Before Reading
Critical Axes and Publication Boundaries
- Article Type: Diagnosis. The topic is organized across five decision axes rather than through a global judgment.
- Evidence Basis: Moderate to strong. 11 evaluated studies, of which 5 have full-text access, and 3 guidelines serve as core anchors.
- Bias Risk: Low to moderate. Source integrity: clean. CoI risk: low.
- Quality Mix: 7 supporting sources (green), 3 with reservations (yellow), 1 critically evaluated (red).
Clinical Question
When does CBCT provide a diagnostically relevant added value compared to conventional 2D imaging—and where does the evidence-free expansion of indications begin?
Executive Summary
The local body of literature for CBCT in dentistry relies on 11 evaluated sources, including three guidelines with supporting evaluations (SADMFR, EAPD, Garib et al.) as well as several systematic reviews and meta-analyses. DDJ reads the strength of conclusion as moderate to strong. The evidence does not fit into a simple yes or no, but rather into five clinical decision axes.
The core message is consistent across all evaluated sources: CBCT offers an undeniable diagnostic gain in defined situations. However, this information gain is only clinically relevant if the specific question cannot be answered with conventional 2D imaging. Where this proof is lacking, there is a risk of evidence-free expansion of indications, which is reinforced by economic and psychological incentives associated with equipment ownership. [3, 4, 5, 7]
Aggregated Bias Risk: low to moderate. CoI Risk: low. The visible conclusion ties strong statements to individual decision axes and avoids a global generalization.
How DDJ Reads This Topic
DDJ treats CBCT as a diagnostic topic with an exposure component. This means: First, the five clinical decision axes are arranged individually, and then an overall reading is built from their intersections. Neither a blanket "CBCT is superior" nor a blanket "CBCT is overrated" is evidence-based.
The technical diagnostic superiority of CBCT over conventional 2D imaging is undisputed. Kiljunen et al. and Jacobs describe this as physically given. [1, 5] However, the central evidence deficit lies one level higher: It is only proven in a few indication areas that the diagnostic information gain actually changes the therapeutic decision. [3, 4, 5]
DDJ therefore strictly distinguishes between technical efficiency (Level 1–2 according to Fryback & Thornbury) and therapeutic efficacy (Level 4–5). Most existing studies fall into the lower levels. [4]
Claim Clusters and Decision Axes
Claim Cluster 1 · ddj_0018_c01
Diagnostic Added Value and Indication Limits
Clinical Axis: Information gain and therapeutic relevance
Why this axis matters: CBCT provides three-dimensional information, but the clinical decision does not depend on the mere existence of a 3D dataset, but rather on whether that dataset specifically changes treatment planning.
Where the signal is stable: The strongest indications lie in pre-operative planning of complex implantations, with retained teeth showing risk signs for nerve contact, and in severe craniofacial anomalies requiring orthognathic surgery. These indications are consistent across all evaluated guidelines. [3, 4, 5, 7]
Where the uncertainty begins: For numerous other indication areas—including routine diagnostics, uncomplicated orthodontics, and general tooth maintenance—there is a lack of robust evidence that CBCT changes the therapeutic decision. The evidence is limited there to technical efficiency and diagnostic accuracy (Level 1–2 according to Fryback & Thornbury), not therapeutic efficacy. [4, 5]
Clinical consequence: The CBCT indication must be linked to a specific, therapeutically relevant question that cannot be answered with 2D imaging alone. Diagnostic information gain alone does not justify inclusion.
Claim Cluster 2 · ddj_0018_c02
Radiation Exposure and Dose Optimization
Clinical Axis: Radiation exposure and dose optimization
Why this axis matters: The effective radiation dose of a CBCT scan varies by more than a factor of 200 depending on the device, field size, and protocol. This enormous range makes protocol-specific optimization a clinically relevant measure—it is not just the device that determines the dose, but the acquisition parameters. [5]